Invacare (IVC +1.1%) finishes the day higher after saying federal prosecutors late Friday accepted the terms of a consent decree and an injunction issued by the FDA following recent inspections of the company's two Ohio manufacturing facilities in Ohio. The injunction limits production and distribution of IVC's custom power and manual wheelchairs, components and sub-assemblies, and temporarily limits wheelchair and power bed design activities.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs